Continuous Renal Replacement Therapy (CRRT) Market Size, End-User Analysis and Future Projections till 2025
The global Continuous Renal Replacement Therapy (CRRT) Market size was valued at around USD 745.4 million in 2016 and is anticipated to reach USD 1.4 billion by 2025, with a CAGR of 7.4%. Acute renal failure is a common complication in the intensive care unit (ICU). Over the last few years, there have been noteworthy technological developments in the delivery of renal replacement therapy, principally as it refers to the critically ill patient population.
The global Continuous Renal Replacement Therapy (CRRT) Market size was valued at around USD 745.4 million in 2016 and is anticipated to reach USD 1.4 billion by 2025, with a CAGR of 7.4%. Acute renal failure is a common complication in the intensive care unit (ICU). Over the last few years, there have been noteworthy technological developments in the delivery of renal replacement therapy, principally as it refers to the critically ill patient population.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Continuous Renal Replacement Therapy (CRRT)
Market Size, End-User Analysis and Future
Projections till 2025
“Continuous Renal Replacement Therapy (CRRT) is a dialysis modality utilized to treat critically ill, hospitalized patients in
the intensive care unit (ICU) who develop acute kidney injury (AKI).”
The global Continuous Renal Replacement Therapy (CRRT) Market size was valued at around USD 745.4 million in
2016 and is anticipated to reach USD 1.4 billion by 2025, with a CAGR of 7.4%. Acute renal failure is a common
complication in the intensive care unit (ICU). Over the last few years, there have been noteworthy technological
developments in the delivery of renal replacement therapy, principally as it refers to the critically ill patient
population.
Continuous Renal Replacement Therapy (CRRT) is a dialysis modality utilized to treat critically ill, hospitalized patients
in the intensive care unit (ICU) who develop acute kidney injury (AKI). Dissimilar to that of chronic kidney disease,
which arises gradually over the period of time, AKI often takes place in hospitalized patients treated in an intensive
care environment, and it classically occurs over a few hours to a few days.
Renal replacement therapy is one treatment modality that strives for the replacement of the excretory function of
the kidney. Renal replacement always utilizes a semi-permeable membrane to accomplish blood purification. It can
be alternating or continuous, and can involve some of the major transport mechanisms such as the convection,
adsorption, diffusion, and ultra-filtration. The effort of this is continuous renal replacement rehabilitation.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/continuous-renal-replacement-therapy-crrt-market
Continuous renal replacement therapy (CRRT) is a widespread optimal for the cure of ICU patients with AKI,
particularly for hemodynamically unbalanced circumstances. CRRT consists of solute removal from blood by
hemofiltration or haemodialysis or a blend of both. CRRT is carried out for about 24 hours in an ICU, making it
relatively different from traditional renal replacement therapies that consist of intermittent haemodialysis durable
from four to six hours or even at a reduced rate. Therefore, CRRT was established in an effort to offer artificial kidney
support to those patients who could not abide the traditional haemodialysis as traditional intermittent haemodialysis
often causes hemodynamic instability in the critically ill patients. The patients in receipt of CRRT can obtain as much
as protein as well as fluid required achieving optimum nutrition.
There are many factors that propel the growth of Continuous Renal Replacement Therapy (CRRT) Market such as rise
in geriatric population, novel product launches, mounting occurrence of Acute Kidney Injury, patient’s inclination
towards Renal Replacement Therapy, awareness regarding the blood purification technique, and development in
technologies. On the other hand, there are factors that hinder the growth of the market like high demand of skilled
ICU nurses, high expenses on Continuous Renal Replacement Therapy and complications of the therapy. The
Continuous Renal Replacement Therapy (CRRT) Market can be classified on the basis product, modality, and
geography.
On the basis of product, Continuous Renal Replacement Therapy (CRRT) Market is classified as CRRT Disposables,
Hemofilters, Bloodlines, CRRT Systems, Dialysate and Replacement Fluids, and the other Disposables. On the basis of
modality, Continuous Renal Replacement Therapy (CRRT) Market is classified Slow Continuous Ultrafiltration (SCUF),
Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), and
Continuous Venovenous Hemodialysis (CVVHD).
On the basis of geography, Continuous Renal Replacement Therapy (CRRT) Market is classified as North America,
Europe, Asia Pacific, and Rest of the World. In 2015, the largest share was held by Europe tracked by North America.
Nevertheless, Asia Pacific’s market is anticipated to grow at the highest rate. The factors that attribute to the high
growth include developments in healthcare, increasing geriatric population, expanding sepsis prevalence, and so on.
The prominent players that fuel the growth of Continuous Renal Replacement Therapy (CRRT) Market include
Infomed SA, Baxter International Inc., Medica S.p.A, Medical Components, Inc., Nikkiso Co., Ltd, NxStage Medical,
Inc., Toray Medical Company Limited, B. Braun Melsungen AG, BellcoS.r.l., Fresenius Medical Care AG & Co. KGaA,
and Asahi Kasei Medical Co., Ltd. Since 2014, Baxter International Inc., has dominated the Continuous Renal
Replacement Therapy (CRRT) Market.
Request Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/continuous-renal-replacement-therapy-crrt-market/request-sample
Market Segment:
Product Outlook (Revenue, USD Million, 2014 - 2025)
• System
• Consumables
Application Outlook (Revenue, USD Million, 2014 - 2025)
• Slow continuous ultra filtration
• Continuous venovenous hemofiltration
• Continuous venovenous hemodialysis
• Continuous venovenous hemodiafiltration
Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/medical-devices
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.
Our representatives strive to understand diverse client requirements and cater to the same with
the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9
Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand
Galleria, Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog: www.millioninsights.blogspot.com